Abstract 2928: Evaluating Cks1-Skp2 interface as an effective therapeutic target for <i>RB1</i>-deficient metastatic castration-resistant prostate cancer (mCRPC)
Authors: Yingjiao Xue, Liang Zhu, Hongling Zhao, Edward L. Schwartz
Published: 2021-07-01
DOI:
10.1158/1538-7445.am2021-2928
Source:
Full article
Abstract
Abstract